HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vogt, P. R. Articles by Turina, M. I. Search for Related Content PubMed PubMed Citation Articles by Vogt, P. R. Articles by Turina, M. I.

European Journal of Cardio-Thoracic Surgery, Vol 11, 53-61, Copyright © 1997 by European Association for Cardio-thoracic Surgery

ARTICLES

Emergency surgery for acute infective aortic valve endocarditis: performance of cryopreserved homografts and mode of failure

PR Vogt, LK von Segesser, R Jenni, U Niederhauser, M Genoni, A Kunzli, J Schneider and MI Turina
Clinic for Cardiovascular Surgery, University Hospital, Zurich, Switzerland.

OBJECTIVE: To describe our experience in the surgical treatment of infective, native and prosthetic aortic valve endocarditis, using cryopreserved homograft valves. METHODS: Between January 1988 and September 1995, cryopreserved homografts were implanted in 49 patients (mean age 47 +/- 15 years; range 19-79) with acute infective endocarditis of the native (21/49; 43%) or the prosthetic (28/49; 57%) aortic valve. Aortic root abscesses were found in 39/49 (80%) patients, ventriculo-aortic disconnection in 27/49 (55%). An intracardiac fistula, originating from the left ventricular outflow tract was found in 25/49 (51%) patients. Indications for emergency surgery were congestive heart failure due to severe aortic valve regurgitation in 44/49 (90%) and systemic emboli in 5/49 (10%) patients. Preoperatively, 23/49 (47%) patients were in New York Heart Association (NYHA) class IV, and 5/49 (10%) were in acute circulatory failure. Mean left ventricular ejection fraction was 53 +/- 10% (25-65). Streptococci (27%) and staphylococci (27%) were the most important microorganisms found. The homograft was implanted as a scalloped freehand valve (34/49; 70%), as an intra-aortic inclusion cylinder (4/49; 6%) or as a free-standing root replacement (12/49; 24%). Combined procedures were necessary in 11/49 (22.5%) patients. RESULTS: Hospital mortality was 8.2% (4/49): 2/49 (4.1%) patients died from endocarditis-related sepsis, one (2%) from low cardiac output and one (2%) from a cerebrovascular accident. After a mean interval of 21 +/- 15 months (2- 48), 9/45 (20%) patients had to be reoperated, all reoperations except one being homograft related. After a mean follow-up of 35 +/- 22 months (2-90), 4/44 (9%) patients had their homograft replaced by a mechanical prosthesis. After 5 years, actuarial freedom from late death was 97 +/- 3%; from late reoperation 69 +/- 9%; from late endocarditis 85 +/- 8%; and from late homograft degeneration 87 +/- 6%. Explanted homografts were acellular and non-vital, containing bacteria and/or leucocytes. B- lymphocytes were found in all and in one, T-cell lymphocytes were present. CONCLUSION: Emergency aortic valve replacement with cryopreserved homografts for acute native or prosthetic aortic valve endocarditis has a low operative mortality. The late incidence of recurrent endocarditis or homograft failure up to 7 years is acceptable. Cryopreserved homografts are non-viable. The presence of T- cell lymphocytes in explanted homografts indicates that rejection may be possible.

This article has been cited by other articles:

				A. Saito, N. Motomura, K. Kakimi, K. Narui, N. Noguchi, M. Sasatsu, K. Kubo, Y. Koezuka, D. Takai, S. Ueha, et al. Vascular allografts are resistant to methicillin-resistant Staphylococcus aureus through indoleamine 2,3-dioxygenase in a murine model J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 159 - 167. [Abstract] [Full Text] [PDF]

				J.-F. Avierinos, F. Thuny, V. Chalvignac, R. Giorgi, L. Tafanelli, J.-P. Casalta, D. Raoult, T. Mesana, F. Collart, D. Metras, et al. Surgical Treatment of Active Aortic Endocarditis: Homografts Are Not the Cornerstone of Outcome Ann. Thorac. Surg., December 1, 2007; 84(6): 1935 - 1942. [Abstract] [Full Text] [PDF]

				C. Schmidtke, G. Dahmen, and H.-H. Sievers Subcoronary Ross Procedure in Patients With Active Endocarditis Ann. Thorac. Surg., January 1, 2007; 83(1): 36 - 39. [Abstract] [Full Text] [PDF]

				R. Bekeredjian and P. A. Grayburn Valvular Heart Disease: Aortic Regurgitation Circulation, July 5, 2005; 112(1): 125 - 134. [Abstract] [Full Text] [PDF]

				A. C. Yankah, M. Pasic, H. Klose, H. Siniawski, Y. Weng, and R. Hetzer Homograft reconstruction of the aortic root for endocarditis with periannular abscess: a 17-year study Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 69 - 75. [Abstract] [Full Text] [PDF]

				T. Ohtsuka, S. Takamoto, M. Ono, and N. Motomura Aortic root replacement and coronary interposition using a cryopreserved allograft and its branch Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 631 - 632. [Abstract] [Full Text] [PDF]

				J. Aagaard and P. V. Andersen Acute endocarditis treated with radical debridement and implantation of mechanical or stented bioprosthetic devices Ann. Thorac. Surg., January 1, 2001; 71(1): 100 - 103. [Abstract] [Full Text] [PDF]

				R. J. Novick Invited commentary Ann. Thorac. Surg., January 1, 2001; 71(1): 104 - 104. [Full Text] [PDF]

				D. Delay, M. Pellerin, M. Carrier, R. Marchand, P. Auger, L. P. Perrault, Y. Hebert, R. Cartier, P. Page, and L. C. Pelletier Immediate and long-term results of valve replacement for native and prosthetic valve endocarditis Ann. Thorac. Surg., October 1, 2000; 70(4): 1219 - 1223. [Abstract] [Full Text] [PDF]

				A. Osman, J. McCann, R. J. Shemin, and H. L. Lazar Accelerated allograft degeneration after aortic valve endocarditis Ann. Thorac. Surg., November 1, 1999; 68(5): 1849 - 1850. [Abstract] [Full Text] [PDF]

				K. Niwaya, C. J. Knott-Craig, K. Santangelo, M. M. Lane, K. Chandrasekaran, and R. C. Elkins Advantage of autograft and homograft valve replacement for complex aortic valve endocarditis Ann. Thorac. Surg., June 1, 1999; 67(6): 1603 - 1608. [Abstract] [Full Text] [PDF]

				P. R. Vogt and M. I. Turina Management of infected aortic grafts: development of less invasive surgery using cryopreserved homografts Ann. Thorac. Surg., June 1, 1999; 67(6): 1986 - 1989. [Abstract] [Full Text] [PDF]

				P. R. Vogt, T. Stallmach, U. Niederhauser, J. Schneider, G. Zund, M. Lachat, A. Kunzli, and M. I. Turina Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults Eur. J. Cardiothorac. Surg., May 1, 1999; 15(5): 639 - 645. [Abstract] [Full Text] [PDF]

				P. R. Vogt, H.-P. B.-L. Rocca, T. Carrel, L. K. von Segesser, C. Ruef, J. Debatin, B. Seifert, W. Kiowski, and M. I. Turina CRYOPRESERVED ARTERIAL ALLOGRAFTS IN THE TREATMENT OF MAJOR VASCULAR INFECTION: A COMPARISON WITH CONVENTIONAL SURGICAL TECHNIQUES J. Thorac. Cardiovasc. Surg., December 1, 1998; 116(6): 965 - 972. [Abstract] [Full Text] [PDF]